Irmlind Gabler

Title: Irmlind Gabler: Innovator in Nucleic Acid Amplification

Introduction

Irmlind Gabler is a notable inventor based in Stockerau, Austria. She has made significant contributions to the field of molecular biology, particularly in the area of nucleic acid amplification. Her innovative work has led to the development of methods that enhance the efficiency of generating labelled nucleic acids.

Latest Patents

Irmlind Gabler holds a patent for a method titled "5' protection dependent amplification." This invention relates to generating a labelled nucleic acid from RNA that includes a 5' protecting group. The method involves obtaining a mixture of template strands of nucleic acids, annealing oligonucleotide primers, and extending these primers to obtain complementary nucleic acid strands. The process allows for the specific generation of labelled nucleic acids that are complementary to RNA templates with a 5' protecting group.

Career Highlights

Irmlind Gabler is currently employed at Lexogen GmbH, a company known for its advancements in genomic technologies. Her work at Lexogen has positioned her as a key player in the development of innovative solutions for nucleic acid research. With her expertise, she has contributed to the company's reputation for excellence in the field.

Collaborations

Irmlind has collaborated with notable colleagues, including Alexander Seitz and Lukas Paul. These collaborations have fostered an environment of innovation and have led to advancements in their shared research interests.

Conclusion

Irmlind Gabler's contributions to nucleic acid amplification demonstrate her commitment to advancing molecular biology. Her innovative methods and collaborative spirit continue to influence the field positively.